Related Experiment Video
Updated: May 19, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Function of adrenomedullin in inflammatory response of liver against LPS-induced endotoxemia
Ryoichi Saito1, Tatsuo Shimosawa, Takehide Ogihara
1Department of Microbiology and Immunology, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Japan.
Abstract:
Adrenomedullin (AM) is a hypotension-causing peptide that was originally isolated from human pheochromocytoma cells, and it has been found to be expressed in various organs, including the liver. As the individual physiological and pathophysiological properties of AM peptide in the liver during endotoxemia in vivo has not yet been examined, we investigated this in experimental endotoxemia using heterozygote AM-deficient (AM(+/-)) mice. The AM concentration of AM(+/-) mice was significantly lesser than that of wild-type (WT) mice in lipopolysaccharide (LPS)-induced endotoxemia. After administering LPS, the survival rate for AM(+/-) mice was significantly lower than that for WT mice. Also, expressions of IL-1β mRNA, and TNF-α mRNA, and NF-κB p65 in the liver were markedly increased and serum ALT greatly elevated in comparison with WT mice. However, supplementation of exogenous AM reversed the deteriorations in mortality and inflammatory responses. Therefore, we conclude that AM plays an important role in regulating systemic inflammation and may be an important intrinsic factor for protecting against liver damage in LPS-induced endotoxemia.
Insights
Adrenomedullin (AM) peptide protects the liver during endotoxemia. Lower AM levels in deficient mice correlated with increased inflammation and mortality, which exogenous AM supplementation reversed.
Area of Science:
- Immunology
- Endocrinology
- Hepatology
Background:
- Adrenomedullin (AM) is a peptide known for its hypotensive effects.
- AM is expressed in various organs, including the liver.
- The role of AM in liver pathophysiology during endotoxemia is not well understood.
Purpose of the Study:
- To investigate the physiological and pathophysiological roles of AM in the liver during lipopolysaccharide (LPS)-induced endotoxemia.
- To examine the impact of AM deficiency on liver function and survival rates in a mouse model.
Main Methods:
- Utilized heterozygote AM-deficient (AM(+/-)) and wild-type (WT) mice in an LPS-induced endotoxemia model.
- Measured AM concentrations, survival rates, and liver markers (IL-1β mRNA, TNF-α mRNA, NF-κB p65, ALT).
- Administered exogenous AM to assess its protective effects.
Main Results:
- AM concentrations were significantly lower in AM(+/-) mice compared to WT mice during endotoxemia.
- AM(+/-) mice exhibited significantly lower survival rates and increased liver inflammation markers (IL-1β, TNF-α, NF-κB p65) and ALT levels post-LPS administration.
- Supplementation with exogenous AM improved survival and reduced inflammatory responses in AM(+/-) mice.
Conclusions:
- AM plays a crucial protective role in the liver during LPS-induced endotoxemia.
- AM is important for regulating systemic inflammation and preventing liver damage.
- AM deficiency exacerbates endotoxemia-induced liver injury and mortality.
Related Concept Videos
Acute Inflammation I: Inflammatory Response
Formation of Lipopolysaccharides
Acute Inflammation III: Local and Systemic Effects
